Key Insights

Highlights

Treatment Research

4 treatments under study, led by Hlx07hlx10 Cisplatin5fu

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 2 (1)

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07887971Phase 1Recruiting

A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors

NCT05221658Phase 2UnknownPrimary

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC

Showing all 2 trials

Research Network

Common Treatments

  • Hlx07hlx10 Cisplatin5fu1
  • Hlx071
  • 225acacaky2519 Therapeutic1
  • 64cucuaky2519 Imaging1

Active Sponsors

  • Aktis Oncology, Inc.1
  • Shanghai Henlius Biotech1

Related Conditions

  • Nsclc Advanced Nonsmall Cell Lung Cancer1
  • Hnscc1
  • Crc1
  • Mcrpc Metastatic Castrationresistant Prostate Cancer1
  • Crc Colorectal Cancer1

Activity Timeline